ApiJect
PrivateLast Round
Debt
Aug 27, 2024
Est. Valuation
$300M
Total Funding Raised
$763M
Company Overview
ApiJect is a healthcare technology company that produces cost-effective prefilled syringes using a single medical-grade plastic resin to enhance the availability of liquid medicines and vaccines while minimizing environmental impact.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Pharma Supply Chain, Biotechnology, Clean Manufacturing, Defense Tech
Business Model
B2G
Customer Profile
Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ApiJect Comparables
Compare ApiJect with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aktiv Pharma Group | 69% | |
ApiJect Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Aug 27, 2024 | ||||
| VC Round | May 18, 2022 | ||||
| Debt | Nov 19, 2020 | ||||
| Grant | May 12, 2020 |
Key People
Founding team and executive leadership
ApiJect Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| U.S. Department of War | Grant |
| Trinity Capital | Debt |
| Royalty Pharma | VC Round |
| U.S. International Development Finance Corporation | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 16, 2026
Opened a 30,000 sq ft pharmaceutical manufacturing facility in Apex, NC.
- Nov 19, 2020
$590M debt round led by U.S. International Development Finance Corporation.
ApiJect Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |